Generic drug user fee amendments
accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016
Accelerating patient access to generic drugs
United States
Congress.
Senate.
Committee on Health, Education, Labor, and Pensions,
creator
text
bibliography
dcu
2018
monographic
eng
ii, 39 pages : illustrations ; 24 cm.
Shipping list no.: 2018-0124-M.
CRDP Program record.
Includes bibliographical references.
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2018]. 1 microfiche : negative.
n-us---
Generic drugs
Prices
United States
Drugs
Prices
United States
Prescription pricing
United States
Drug accessibility
Government policy
United States
Drugs
Generic substitution
Drug approval
United States
Drug approval
Drugs
Generic substitution
Drugs
Prices
Generic drugs
Prices
Prescription pricing
United States
KF26 .L27 2016a
Y 4.L 11/4:S.HRG.114-730
Y 4.L 11/4:S.HRG.114-730
Generic drug user fee amendments
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions,
(DLC) 2017433645
(OCoLC)1020497836
Generic drug user fee amendments (OCoLC)1021286902
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
S. hrg. ; 114-730
United States.
Congress.
Senate.
PUCPR
190219
20190920142840.0
on1086348873
eng